home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Courses and Workshops  

FDA 510(k) Requirements, Submission, and Clearance: Best Practices

  October 01, 2015  

Compliance Trainings, Mississauga

Description :

This presentation will walk you through how to prepare and submit a traditional premarket notification [510(k)] for successful clearance from US FDA. The premarket notification [510(k)] is the most common pathway to market for medical devices including in vitro diagnostic medical devices (IVDs).

Over the years, the 510(k) program has significantly evolved, affecting the 510(k) decision-making process.  On July 28, 2014, FDA issued the finalized 510(k) guidance integrating a total of 400 comments received in response to the Draft Guidance issued on December 28, 2011. To expedite the process of bringing a product to market through the 510(k) program, it is imperative the medical device makers understand the recent changes, prepare and submit a quality 510(k) in a way to expedite the review process for fast and successful clearance.

In this 60-min presentation, the speaker will guide you through the details of the required elements in your 510(k) submission for successful clearance.

From this webinar, you will

Gain and receive great guidance on 510(k) preparation, submission and clearance

Get the latest information

Learn the critical areas and common mistakes

Improve your current practice

Recognize what is important

Become better aware of and get familiar with the 510(k) process and much more.


Areas Covered in the Session :

Applicable statute(s), regulations, and definitions

Device classification

Who is subject to a 510(k)

FDA guidance for 510(k) program

What actions require a 510(k) including three types of 510(k)s

How to identify a predicate(s), if any.

510(k) program (Refuse to Accept Policy) – Compiled RTA Items Cited by FDA

e-Copy Program

Product type-specific 510(k) contents-recently cleared

What to include and address in 510(k) submissions.

510(k) contents and format

How to present scientific, technical, and/or clinical data.

How to demonstrate substantial equivalence (SE).

How to increase 510(k) submission quality.

How to respond to FDA’s request of additional information.

How to resolve different opinions between the submitter and FDA reviewer(s), if any.

PASS-IT suggestions/recommendations


Who Will Benefit:

Medical Device Quality and Compliance Professionals

Pharmaceutical Compliance Professionals


Regulatory Affairs




Clinical Affairs

Research & Development




Anyone Interested in the 510(k) Matters

Organized by: Compliance Trainings
Invited Speakers:

Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor (www.RegulatoryDoctor.com). Dr. Lim frequently presents global regulatory and quality compliance topics in various forums and meetings. Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past seven years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009. Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author. Dr. Lim leads and directs all research projects including pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor.

Deadline for Abstracts: 2015-10-05

For more information on this webinar visit




To register this webinar 

E-mail: suzzane.d@compliancetrainings.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.